Market Research Reports

All Reports Home

Categories

Countries

Consumer Healthcare Reports

Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market By Product Type (Omega-3, Omega-6), By Food Source (Plant Sources, Animal Sources), By Application (Pharmaceutical, Dietary Supplements, Food and Beverages, Animal Feed, Others), By Country, Competition, Forecast & Opportunities, 2019-2029F

Increasing prevalence of lifestyle-related diseases and rising health awareness are factors driving the Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market Read More

United Kingdom Pregnancy Testing Kits Market By Product (Home Pregnancy Tests (HPT), Digital Devices, and Others), By Test Type (Urine Test for HCG, Blood Test for HCG, and Others), By End User (Household, Gynecology Clinics, Hospitals), By Region, Competition, Forecast & Opportunities, 2019-2029F

Advancements in technology and rapid growth of e-commerce are factors driving the United Kingdom Pregnancy Testing Kits Market in the forecast period 2025-2029.Read More

South Korea Telemedicine Market By Component (Products, Services), By Application (Teleradiology, Telepsychiatry, Telepathology, Tele dermatology, Others), By End User (Providers, Payers, Patients and Others), By Region, Competition, Forecast & Opportunities, 2019-2029F

Increasing demand for healthcare services and advances in technology is expected to drive the South Korea Telemedicine Market growth in the forecast period, Read More

North America Clot Management Devices Market, By Product (Neurovascular Embolectomy Devices, Embolectomy Balloon Catheters, Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) devices, Inferior vena cava filters (IVCF)), By End-User (Diagnostic Centers, Hospitals), By Country, Competition, Forecast & Opportunities, 2019-2029F

Rising Incidence of Venous Thromboembolism (VTE) and Prevalence of Cardiovascular Risk Factors are factors driving the North America Clot Management Devices Read More

North America RNA Therapeutics Market, By Product (Vaccines, Drugs), By Type (mRNA Therapeutics, RNA Interference (RNAi) Therapeutics, Antisense Oligonucleotide (ASO) Therapeutics, Other Therapeutics), By Indication (Infectious Diseases, Rare Genetic Diseases/Hereditary Diseases, Other Indications), By End User (Hospitals and Clinics, Ambulatory Surgical Centers, Others), By Country, Competition, Forecast and Opportunities, 2019-2029F

Rising prevalence of genetic disorders is expected to drive the North America RNA Therapeutics Market in the forecast period 2025-2029.Read More

Spain Dental Disposables Market, By Type (Disposable Dental Examination Kit, Disposable Saliva Evacuation Products, Sponges and Gauze Products, Disposable Air/Water Syringe Tips, Consumables (Tray, Paper Toothbrushes, Mouthwash, Hand Sanitizers, Washing Soap, X-ray Films), Disposable Impression Trays, Disposable Micro-applicators, Dental Mouth Opener, Silicone Structures, Restorative/Protective Materials, Medications, Sedative Products, Paper Clips, Band Adaptors, Blocking Structures, Others (Dental Bibs, etc.)), By Application (Cosmetic Dentistry, Teeth Straightening, Dental Implants, Others (Composite Filling, Gum Reshaping, etc.)), By End User (Hospitals & Clinics, Dental Laboratories, Others (Academic & Research Institutions, etc.)),By Region, Competition, Forecast and Opportunities, 2019-2029F

A growing population, supportive government policies, and an aging population are factors driving the Spain Dental Disposables market in the forecast period Read More

Spain Biomaterial Wound Dressing Market By Product (Alginate Dressing, Hydrocolloids, Skin Substitutes, Others {Collagen Dressing, Foam Dressing, etc.}), By Type (Primary, Secondary), By Application (Wounds, Burns, Ulcers, Others (Surgical & Traumatic Wounds}), By End User (Hospitals & Clinics, Ambulatory Surgical Centres, Homecare), By Region, Competition, Forecast and Opportunities, 2019-2029F

Increase in chronic diseases and the demand for more effective wound care solutions are factors driving the Spain Biomaterial Wound Dressing market in the Read More

Asia-Pacific Multi-Cancer Early Detection Market, By Type (Liquid Biopsy, Gene Panel, LDT, & Others), By End-Use (Hospitals & Clinics, Diagnostics Laboratories, Others), By Country, Competition, Forecast and Opportunities, 2019-2029F

Growing demand for liquid biopsies is expected to drive the Asia-Pacific Multi-Cancer Early Detection Market in the forecast period 2025-2029.Read More

Egypt Cancer Diagnostics Market By Product (Consumable, Instruments), By Technology (IVD Testing, Imaging, Biopsy), By Application (Breast Cancer, Lung Cancer, Colorectal Cancer, Others), By End User (Hospitals & Clinics, Diagnostic Laboratories, Others), By Region, Competition, Forecast & Opportunities, 2019-2029F

Increasing prevalence of cancer is expected to drive the Egypt Cancer Diagnostics Market growth in the forecast period 2025-2029.Read More

Spain CAR-T Cell Therapy Market By Product Type (Yescarta (Axicabtagene Ciloleucel), Kymriah (Tisagenlecleucel), Others), By Tumor Type (Hematological Malignancies, Solid Tumors), By Indication (Diffused Large B-Cell Lymphoma (DLBCL), Acute Lymphoblastic Leukemia (ALL), Follicular Lymphoma (FL), Mantle Cell Lymphoma (MCL), Others), By Treatment Type (Single Treatment, Combination Treatment), By Targeted Antigen (CD 19, BCMA (B-Cell Maturation Antigen), Others), By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Others), By Region, Competition, Forecast and Opportunities, 2019-2029F

Increasing awareness of its potential benefits and its efficacy in treating specific types of cancer is driving the Spain CAR-T Cell Therapy market in the Read More

France Biochip Market By Technology (Microarray, Microfluidics), By Type (DNA Chips, Lab-On-a-Chips, Protein Chips, Others), By Application (Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Others), By End User (Hospitals & Diagnostics Centers, Academic & Research Institutes, Biotechnology & Pharmaceutical Companies, Others), By Region, Competition, Forecast & Opportunities, 2019-2029F

Technological advancements, the clinical diagnostics revolution, and the rise of personalized medicine are factors driving the France Biochip market in the Read More

Japan Sarcoma Drugs Market, By Treatment Type (Chemotherapy, Targeted Therapy, Others), By Distribution Channel (Hospital pharmacy, Retail pharmacy, Online Pharmacy), By Region, Competition Forecast & Opportunities, 2020-2030F

Advancements in Molecular and Genetic Research and Growing Incidence of Sarcoma Cases are factors driving the Japan Sarcoma Drugs market in the forecast period Read More

Japan Infectious Disease Drugs Market, By Disease (HIV, Influenza, Hepatitis, Tuberculosis, Malaria, Other), By Treatment (Antibacterial, Antiviral, Antiparasitic, Other), By Region, Competition Forecast & Opportunities, 2020-2030F

Increasing Incidence of Infectious Diseases and Technological Advancements in Drug Development are factors driving the Japan Infectious Disease Drugs market in Read More

Japan Prostate Cancer Drugs Market, By Drug Class (Hormonal Therapy, Chemotherapy, Immunotherapy, Targeted Therapy), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Sales, Others), By End User (Clinics, Hospital, Others), By Region, Competition, Forecast & Opportunities, 2020-2030F

Rising Incidence of Prostate Cancer and Advancements in Treatment Technologies are factors driving the Japan Prostate Cancer Drugs market in the forecast period Read More

Japan Respiratory Drugs Market, By Type (Asthma, Chronic Obstructive Pulmonary Disease, Idiopathic Pulmonary Fibrosis, Cystic Fibrosis), By Application (Hospitals, Ambulatory Care, Homecare, Pharmacies), By Age Group (Pediatric, Adult), By Distribution Channel (Prescription, Over-the-Counter), By Region, Competition Forecast & Opportunities, 2020-2030F

Rising Incidence of Respiratory Diseases and Advancements in Drug Development are factors driving the Japan Respiratory Drugs market in the forecast period Read More

Japan Renal Cancer Drugs Market, By Type (Renal Cell Carcinoma (RCC), Papillary Renal Cell Carcinoma, Chromophobe Renal Cell Carcinoma, Unclassified Renal Cell Carcinoma, Transitional Cell Carcinoma, Wilms Tumor (Nephroblastoma), Renal Sarcoma, Angiomyolipoma, Oncocytoma, Others), By Drug Class (Monoclonal Antibodies, mTOR Inhibitors, Immune Checkpoint Inhibitor, Combined Therapies, Interleukin-2, Alpha-Interferon, Others), By Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy), By Region, Competition Forecast & Opportunities, 2020-2030F

Rising Incidence and Prevalence of Renal Cancer and Increased Investment in Research and Development (R&D) are factors driving the Japan Renal Cancer Drugs Read More

Japan Cancer Supportive Care Market, By Therapeutics Class (G-CSFs (Granulocyte-colony Stimulating Factors), ESAs (Erythropoiesis Stimulating Agents), Anti-emetics, Bisphosphonates, Opioids, NSAIDs, Others), By Region, Competition Forecast & Opportunities, 2020-2030F

Increasing Cancer Incidence and Rising Awareness and Demand for Quality of Life Improvements are factors driving the Japan Cancer Supportive Care market in the Read More

Japan Biosimilars Market, By Product (Monoclonal Antibodies, Recombinant Hormones, Immunomodulators, Anti-inflammatory Agents, Other), By Application (Blood Disorders, Growth Hormonal Deficiency, Chronic and Autoimmune Disorders, Oncology, Other), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region, Competition Forecast & Opportunities, 2020-2030F

Rising Healthcare Costs and Demand for Affordable Therapies and Technological Advancements in Biomanufacturing are factors driving the Japan Biosimilars market Read More

Japan Pulmonary Arterial Hypertension Drugs Market, By Drug Class (Endothelin Receptor Antagonists (ERAs), Phosphodiesterase-5 (PDE-5) Inhibitors, Soluble Guanylate Cyclase (sGC) Stimulators, Prostacyclin Analogues, Calcium Channel Blockers, Others), By Route of Administration (Oral, Inhalation, Intravenous, Subcutaneous), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region, Competition, Forecast & Opportunities, 2020-2030F

Advancements in Medical Research and Drug Development and Increasing Prevalence of Pulmonary Arterial Hypertension (PAH) are factors driving the Japan Pulmonary Read More

Japan Rheumatoid Arthritis Drugs Market, By Molecule Type (Pharmaceuticals, Biopharmaceuticals), By Drug Class (Non-steroidal Anti-inflammatory Drugs (NSAIDs), Corticosteroids, Analgesics, Other) By Distribution Channel (Prescription, Over-the-counter (OTC)), By Region, Competition, Forecast & Opportunities, 2020-2030F

Rising Incidence and Prevalence of Rheumatoid Arthritis (RA) and Advancements in Drug Development and Innovation are factors driving the Japan Rheumatoid Read More

Prev    Page 76 of 93 Next